Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    19458321 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Raltegravir (Isentress) Pilot Study in Relapsing Multiple Sclerosis
Condition: Relapsing Remitting Multiple Sclerosis
Intervention: Drug: Raltegravir

Study has passed its completion date and status has not been verified in more than two years.